Free same-day US shipping on orders over $150.00 · bulk pricing on 2+ vials
For research use only. Not for human or animal consumption.
Compound profile

MOTS-c Peptide: Mitochondrial-Derived Biology and Mechanism of Action

MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) that has become a reference example of how the mitochondrial genome can encode short bioactive peptides with signaling roles beyond the organelle. Unlike the canonical peptide hormones synthesized from nuclear genes, MOTS-c is translated from a small open reading frame embedded within the 12S ribosomal RNA region of mitochondrial DNA. This profile summarizes what the peer-reviewed literature describes about MOTS-c: its molecular identity, the proposed AMPK-centered mechanism of action, its stress-dependent translocation to the nucleus, and its interaction with the folate–methionine one-carbon cycle. All statements here are literature-framed and molecular; the material is a reference compound for in-vitro and research use only.

What a mitochondrial-derived peptide is

Mitochondrial-derived peptides are short polypeptides encoded by small open reading frames (sORFs) located within the mitochondrial genome, primarily inside the 12S and 16S ribosomal RNA genes. The discovery that the ~16.5 kb human mitochondrial DNA harbors coding sequences beyond its 13 canonical oxidative-phosphorylation subunits reframed the mitochondrion as a signaling hub rather than a purely metabolic one. Humanin, encoded in the 16S rRNA region, was the first characterized MDP; MOTS-c, encoded in the 12S rRNA region, was the second and is among the most studied.

The name MOTS-c stands for mitochondrial open reading frame of the twelve-S rRNA type-c. Because it originates from mtDNA, MOTS-c biology is tied to the same maternally inherited, high-copy-number genome that encodes the respiratory chain, which the literature has used to investigate how mitochondrial and nuclear genomes communicate. This retrograde signaling — information flowing from mitochondrion to nucleus — is the conceptual frame within which MOTS-c is most often studied.

  • Encoded by small open reading frames within mitochondrial ribosomal RNA genes.
  • MOTS-c derives from the 12S rRNA region; Humanin from the 16S rRNA region.
  • Studied as a mediator of retrograde (mitochondrion-to-nucleus) signaling.

Molecular identity of MOTS-c

MOTS-c is a 16-residue peptide with the amino-acid sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (one-letter: MRWQEMGYIFYPRKLR). Its average molecular mass is approximately 2174 g/mol. The sequence carries three basic residues (two arginine, one lysine) that give the peptide a net positive charge at physiological pH, a feature relevant to the membrane and nuclear-localization behavior discussed below.

As with other research peptides, the values that matter analytically are the sequence, the calculated theoretical mass, and the observed mass by mass spectrometry, which should agree within instrument tolerance. There is no widely assigned CAS number for MOTS-c in general reference use, so identity in a laboratory setting is best confirmed by sequence-derived mass and reversed-phase HPLC purity rather than by a registry identifier.

  • 16 amino acids: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg.
  • One-letter sequence: MRWQEMGYIFYPRKLR.
  • Average molecular mass approximately 2174 g/mol.
  • Net positive charge from two arginine and one lysine residue.

The AMPK activation pathway

The central mechanistic finding in the MOTS-c literature is activation of AMP-activated protein kinase (AMPK), the cell's principal energy-sensing kinase. AMPK is activated when the cellular AMP/ATP ratio rises, and once active it shifts metabolism toward catabolic, ATP-generating processes while suppressing anabolic ones. Studies report that MOTS-c increases AMPK phosphorylation and thereby engages the downstream network that AMPK controls, including regulators of glucose uptake and fatty-acid oxidation.

Importantly, the literature describes MOTS-c as acting on AMPK indirectly rather than binding the kinase itself. The proposed route runs through the folate–methionine one-carbon cycle: MOTS-c is reported to interfere with this cycle in a way that raises cellular levels of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a purine-biosynthesis intermediate and a well-known endogenous AMPK activator. Accumulating AICAR then activates AMPK. This places MOTS-c upstream of AMPK, working through metabolite flux rather than direct receptor agonism.

  • MOTS-c is reported to increase AMPK phosphorylation (activation).
  • Action on AMPK is indirect, via one-carbon metabolism rather than direct binding.
  • AICAR accumulation is the proposed proximal AMPK-activating signal.
  • Downstream, AMPK governs glucose uptake and fatty-acid oxidation programs.

Interaction with the folate and methionine cycle

The folate cycle and the coupled methionine cycle together form one-carbon metabolism, the network that supplies methyl and formyl groups for nucleotide synthesis, methylation reactions, and redox balance. MOTS-c has been reported to modulate the folate-dependent de novo purine biosynthesis pathway. Because AICAR is an intermediate in that pathway, a MOTS-c-driven perturbation of one-carbon flux provides a mechanistic link between the peptide and AMPK activation.

This coupling is significant because it ties MOTS-c to a metabolic node that is itself sensitive to nutrient status. One-carbon metabolism integrates the availability of folate, methionine, serine, and glycine, so the pathway through which MOTS-c is proposed to signal is inherently nutrient-responsive. The literature uses this to frame MOTS-c as a metabolite-level regulator whose effect is contextual rather than constitutive — most pronounced when metabolic demand shifts.

  • One-carbon metabolism supplies groups for purine synthesis and methylation.
  • MOTS-c is reported to modulate folate-dependent de novo purine biosynthesis.
  • AICAR sits in this pathway, linking one-carbon flux to AMPK activation.
  • The node is nutrient-sensitive, making the signal context-dependent.

Nuclear translocation under metabolic stress

A defining feature of MOTS-c biology is that its subcellular localization is dynamic and stress-dependent. Under basal conditions the peptide is associated largely with the cytoplasm and mitochondria, but under metabolic stress — glucose restriction, oxidative stress, or AMPK activation — studies report that MOTS-c translocates to the nucleus. This regulated movement is what allows a mitochondrially encoded peptide to influence nuclear gene expression, the essence of retrograde signaling.

Once in the nucleus, MOTS-c has been reported to associate with stress-responsive transcription factors, including members of the antioxidant-response network such as NRF2 (nuclear factor erythroid 2-related factor 2), and to influence the expression of genes carrying antioxidant response elements. The peptide's positively charged residues are consistent with the nucleic-acid and chromatin interactions implied by a nuclear role. In this model MOTS-c functions as a mitochondrial signal that, when energy status is challenged, helps coordinate a nuclear adaptive transcriptional program.

  • Localization is dynamic: cytoplasmic/mitochondrial at baseline.
  • Metabolic stress and AMPK activation drive nuclear translocation.
  • In the nucleus, reported to engage stress transcription factors including NRF2.
  • Provides a route for mtDNA-encoded regulation of nuclear gene expression.

Studied role in metabolic homeostasis

Because it converges on AMPK, MOTS-c has been investigated in preclinical models of metabolic regulation. The literature examines its relationship to glucose handling, insulin sensitivity, and lipid metabolism in cell and rodent systems, framing MOTS-c as a candidate regulator of whole-organism metabolic homeostasis. Reports also describe circulating MOTS-c levels changing with age and metabolic state, which has motivated interest in the peptide as a readout of mitochondrial signaling capacity.

These findings are preclinical and mechanistic. The literature investigates how MOTS-c influences metabolic pathways in defined experimental systems; it does not establish any therapeutic use, and the compound described here is not for human or animal administration. The value of the metabolic literature for a researcher is that it maps the pathways — AMPK, one-carbon metabolism, and stress-responsive transcription — through which any observed effect is proposed to operate.

  • Investigated in cell and rodent models for glucose and lipid metabolism.
  • Circulating levels reported to vary with age and metabolic state.
  • Findings are mechanistic and preclinical, not clinical or therapeutic.

Exercise-mimetic research framing

MOTS-c is frequently discussed in the literature as an exercise-associated or exercise-mimetic signal, because AMPK activation is one of the core molecular consequences of physical exercise. Studies have reported that MOTS-c expression and nuclear localization respond to exercise stimuli, and that the peptide engages several of the same downstream programs — AMPK signaling, metabolic gene expression, and adaptive stress responses — that exercise is known to activate. This has made MOTS-c a model compound for studying how a single mitochondrial peptide can recapitulate parts of an exercise-like metabolic signature in experimental systems.

This framing is a research analogy, not a claim. Describing MOTS-c as exercise-mimetic in the literature means it activates overlapping molecular pathways under experimental conditions, which is useful for interrogating those pathways in vitro. It does not imply any performance, fitness, or physiological benefit in humans, and no such use is described or endorsed here.

  • AMPK activation is a shared node between exercise physiology and MOTS-c.
  • Reported to respond to exercise stimuli in experimental models.
  • Exercise-mimetic is a mechanistic analogy for pathway overlap, not a claim.

Laboratory handling considerations

MOTS-c is typically supplied as a lyophilized powder for laboratory reconstitution. As a small, charged, methionine-containing peptide it shares the general stability concerns of research peptides: methionine residues are susceptible to oxidation (a characteristic +16 Da mass shift), and repeated freeze–thaw cycling of reconstituted solution can degrade the material. For in-vitro work, reconstitution in an appropriate sterile solvent, aliquoting to avoid repeated thawing, and storage of the lyophilate cold and desiccated are the standard practices covered in dedicated handling guides.

These considerations pertain strictly to bench handling of a reference material, not to any human regimen. As with any research peptide, identity and purity should be confirmed against a lot-specific certificate of analysis before use — the observed mass should match the sequence-derived value of approximately 2174 g/mol, and the HPLC chromatogram should show a single dominant, symmetric peak.

  • Supplied lyophilized; reconstitute in an appropriate sterile solvent for in-vitro use.
  • Two methionine residues make oxidation a relevant degradation route (+16 Da).
  • Aliquot to limit freeze–thaw cycles; store lyophilate cold and desiccated.
  • Confirm identity and purity against a lot-specific COA before use.
Frequently asked
What is MOTS-c and where does it come from?

MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded by a small open reading frame within the 12S ribosomal RNA region of mitochondrial DNA. It is one of the most studied examples of a bioactive peptide originating from the mitochondrial genome rather than the nuclear genome.

What is the proposed mechanism of action of MOTS-c?

The literature centers on AMPK activation. MOTS-c is reported to act indirectly by perturbing the folate-dependent one-carbon cycle, which raises cellular AICAR, an endogenous AMPK activator. It does not appear to bind AMPK directly but to work upstream through metabolite flux.

Why does MOTS-c move to the nucleus?

MOTS-c localization is stress-dependent. Under metabolic stress such as glucose restriction or oxidative stress, and under AMPK activation, studies report that MOTS-c translocates from the cytoplasm to the nucleus, where it engages stress-responsive transcription factors including NRF2 to influence adaptive gene expression.

How does MOTS-c interact with the folate and methionine cycle?

MOTS-c is reported to modulate folate-dependent de novo purine biosynthesis within one-carbon metabolism. Because AICAR is an intermediate in that pathway, this interaction links MOTS-c to AMPK activation and makes its signaling sensitive to nutrient status.

Why is MOTS-c described as an exercise mimetic?

Because AMPK activation is a core molecular consequence of exercise, and MOTS-c engages overlapping pathways in experimental systems. The term is a mechanistic analogy describing shared molecular signaling, not a claim of any performance or health benefit.

Is MOTS-c intended for human use?

No. MOTS-c described here is a reference compound for in-vitro and research use only. The literature summarized is preclinical and mechanistic, and none of it authorizes or describes human or animal administration.

Research Use Only. All products and information referenced by Kairo Labs are intended strictly for laboratory research and educational purposes. They are not for human or animal consumption, and not for diagnostic, therapeutic, or clinical use. This content describes mechanisms, molecular properties, and handling as studied in the scientific literature; it is educational, not medical advice, and not a recommendation to use any compound in humans or animals. Researchers are responsible for handling all materials in accordance with applicable laws, regulations, and institutional safety protocols.